UC BON.CAP.CERT. 12/24 NDX1/ DE000HD0MVM3 /
22/05/2024 11:45:47 | Chg.+0.050 | Bid13:02:30 | Demandez à13:02:30 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
15.320EUR | +0.33% | 15.280 Bid taille: 8,000 |
15.310 Ask la taille: 8,000 |
NORDEX SE O.N. | - - | 31/12/2024 | Call |
Newsfile Corp
13:00
Flow Beverage Corp. to Present at Water Tower Research's Inaugural Consumer Products Virtual Investo...
GlobeNewswire
13:00
Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention
GlobeNewswire
13:00
Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual...
GlobeNewswire
13:00
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-...
GlobeNewswire
13:00
Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for De...
GlobeNewswire
13:00
Will AI Make Leaders Obsolete? AIIR Teams Up with Microsoft and Wharton to Consider the Implications
GlobeNewswire
13:00
Atea Pharmaceuticals Presents New Data Showcasing Potential Best-in-Class Combination Profile of Bem...
GlobeNewswire
13:00
Nokia successfully completes acquisition of Fenix Group, accelerating U.S. strategy
GlobeNewswire
12:56
Gate.io Celebrates 11th Anniversary with Prize Activities and Vision for the Future
GlobeNewswire
12:55
Antion Biosciences announces development of safety-enhanced and off-the-shelf CAR T-cells for autoim...
Newsfile Corp
12:36
Early Leak Unveils Exciting Lineup of Speakers and Sponsors for ADFO Summit 2024
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page